Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Poikkeus, P.
Right arrow Articles by Tiitinen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poikkeus, P.
Right arrow Articles by Tiitinen, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 17, No. 7, 1901-1905, July 2002
© 2002 European Society of Human Reproduction and Embryology

Serum HCG 12 days after embryo transfer in predicting pregnancy outcome

P. Poikkeus1,2, V. Hiilesmaa1 and A. Tiitinen1,3

1 Department of Obstetrics and Gynaecology, Helsinki University Central Hospital and 2 Department of Obstetrics and Gynaecology, South Karelia Central Hospital, Finland

BACKGROUND: Assisted reproduction treatment (ART) entails a risk of ectopic pregnancy and early pregnancy loss. Serum HCG has been found to be predictive of pregnancy outcome. Our aim was to assess the clinical value of a single early HCG assay in ART pregnancies taking into account the aetiology and treatment of infertility. METHODS: During 1994–1999, we studied 774 embryo transfer cycles resulting in pregnancy defined as a serum HCG concentration of 5 IU/l on day 12 following embryo transfer. The treatment included IVF in 518, ICSI in 119, and frozen embryo transfer in 137 cycles. Serum HCG concentrations were measured by fluoroimmunometric assay. Pregnancies were classified as viable (live fetus at 22 weeks gestation) or non-viable (biochemical pregnancy, miscarriage, ectopic pregnancy and molar pregnancy). Data on the outcomes were retrospectively retrieved from the records. RESULTS: The median HCG concentration was 126 IU/l in viable pregnancies and 31 IU/l in non-viable pregnancies (P < 0.0001). The median HCG concentration was 115 IU/l in singleton pregnancies and 201 IU/l in multiple pregnancies (P < 0.0001). Male factor infertility was associated with viable pregnancies (P = 0.004) and tubal factor with non-viable pregnancies (P = 0.003); the lowest HCG level (88 IU/l) was observed in subjects with both male factor infertility and ICSI treatment (P = 0.001). An HCG value of 76 IU/l emerged as the most suitable cut-off point to predict viable pregnancy. Probabilities of each type of outcome related to the HCG level are given. CONCLUSIONS: A single HCG reading on day 12 after embryo transfer helps to plan the subsequent follow-up. Male factor infertility and ICSI are associated with relatively low HCG values in viable pregnancies.

Key words: assisted reproduction treatment/ectopic pregnancy/HCG/infertility/pregnancy outcome

3 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, PO Box 140, 00029 HUS, Finland. E-mail: aila.tiitinen{at}hus.fi


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
S. Tong, L. Rombauts, J. Onwude, B. Marjono, and E.M. Wallace
Highly specific and sensitive rise in Days 14 17 pro-{alpha}C inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles
Hum. Reprod., August 1, 2007; 22(8): 2249 - 2253.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Tang, J. Glanville, N. Orsi, J. H. Barth, and A. H. Balen
The use of metformin for women with PCOS undergoing IVF treatment
Hum. Reprod., June 1, 2006; 21(6): 1416 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. Tong, E. M. Wallace, and L. Rombauts
Association Between Low Day 16 hCG and Miscarriage After Proven Cardiac Activity
Obstet. Gynecol., February 1, 2006; 107(2): 300 - 304.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Rull and M. Laan
Expression of {beta}-subunit of HCG genes during normal and failed pregnancy
Hum. Reprod., December 1, 2005; 20(12): 3360 - 3368.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
H. Fernandez and A. Gervaise
Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy
Hum. Reprod. Update, November 1, 2004; 10(6): 503 - 513.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. De Neubourg, J. Gerris, K. Mangelschots, E. Van Royen, M. Vercruyssen, and M. Elseviers
Single top quality embryo transfer as a model for prediction of early pregnancy outcome
Hum. Reprod., June 1, 2004; 19(6): 1476 - 1479.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.